Traws Pharma, Inc.
NASDAQ: TRAW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Iain D. Dukes
- Employees
- 6
- Headquarters
- Newtown, United States
- IPO year
- 2013
- Market cap
- $7.9M
- Website
- https://www.trawspharma.com
Loading TRAW…
Loading profile data…Frequently asked questions about TRAW
What does Traws Pharma, Inc. (TRAW) do?
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-...
Where does TRAW trade?
Traws Pharma, Inc. (TRAW) trades on the NASDAQ Global Market.
What sector is TRAW in?
Traws Pharma, Inc. (TRAW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Traws Pharma, Inc.?
Iain D. Dukes is the chief executive officer of Traws Pharma, Inc. (TRAW).
Where is Traws Pharma, Inc. headquartered?
Traws Pharma, Inc. is headquartered in United States.
Does TRAW pay a dividend?
Traws Pharma, Inc. (TRAW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TRAW go public?
Traws Pharma, Inc. (TRAW) completed its initial public offering in 2013.